Tres Cantos Open Lab: celebrating a decade of innovation in collaboration to combat endemic infectious diseases

Tres Cantos Open Lab is a collaborative initiative that integrates teams from academia and GlaxoSmithKline to enable rapid testing of innovative therapeutic hypotheses for endemic infectious diseases. Here, we provide an overview of the key scientific achievements in its first decade. Tres Cantos Op...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature reviews. Drug discovery 2021-11, Vol.20 (11), p.799-800
Hauptverfasser:	Calderón, Felix, Ballell, Lluis, Barros, David, Bilbe, Graeme, Cammack, Nicholas, Gabarró, Raquel, Halsey, Audra, Heaton, Penny M., Kang, Gagandeep, Mizrahi, Valerie, Nathan, Carl, Strange, Mike E., Williams, Pauline M., Winzeler, Elizabeth A., Fairlamb, Alan H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anniversaries Biomedical Research Biomedicine Biotechnology Cancer Research Collaboration Comment Diffusion of Innovation Drug Discovery Endemic Diseases - prevention & control Forecasting Humans Hypotheses Infection Control Infectious diseases Intersectoral Collaboration Laboratories Medicinal Chemistry Molecular Medicine Pharmacology/Toxicology Planning Spain
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Tres Cantos Open Lab is a collaborative initiative that integrates teams from academia and GlaxoSmithKline to enable rapid testing of innovative therapeutic hypotheses for endemic infectious diseases. Here, we provide an overview of the key scientific achievements in its first decade. Tres Cantos Open Lab is a collaborative initiative that integrates teams from academia and GlaxoSmithKline to enable rapid testing of innovative therapeutic hypotheses for endemic infectious diseases. Here, we provide an overview of the key scientific achievements in its first decade.
ISSN:	1474-1776 1474-1784
DOI:	10.1038/d41573-021-00143-2